This exploratory study will fill a knowledge gap regarding the pharmacokinetic effects of isotretinoin on the etonogestrel (ENG) contraceptive implant.
The Investigators will enroll only women with an etonogestrel contraceptive implant in place who are initiating isotretinoin therapy through their dermatologist. The Investigators will monitor the subjects serum etonogestrel concentration during isotretinoin therapy but no medications will be provided through this study. No medical devices will be inserted as part of this study either.
Study Type
OBSERVATIONAL
Enrollment
9
University of Colorado Denver
Aurora, Colorado, United States
Serum Etonogestrel (ENG) Level
ENG levels will be measured prior to initiation of isotretinoin therapy.
Time frame: Baseline (enrollment)
Serum Etonogestrel (ENG) Level
ENG levels will be measured 4 weeks after of initiation of isotretinoin therapy.
Time frame: 4 weeks
Serum Etonogestrel (ENG) Level
ENG levels will be measured 9 weeks after of initiation of isotretinoin therapy.
Time frame: 9 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.